Brief: Entrada Therapeutics Reports Third Quarter 2021 Financial Results
09/12/2021 12:42
Dec 9 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
* ENTRADA THERAPEUTICS INC - QTRLY NET LOSS PER SHARE
ATTRIBUTABLE
TO COMMON STOCKHOLDERS $9.78
Source text for Eikon: ID:nGNX2zb88R
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview